Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Is Eradicating Viral Hepatitis by 2030 a Realistic Goal?
A new analysis sheds light on what is needed to hit this benchmark.
Lowering the Risk of Hepatitis C Virus Reinfection in HIV-Positive Men
Even when men who have sex with men are aware of the risk of hepatitis C infection, they aren’t always confident in their ability to go against the expectations of their peer group.
2019 Brings End to Hepatitis C Virus Treatment Rationing in Oregon
Patients with the hepatitis C virus who are on Medicaid in Oregon can expect to receive curative treatment in 2019, without having to wait for liver damage to set in.
Shorter Treatment for Hepatitis C Virus Possible with Earlier Detection of Infection
Successful treatment of recently acquired hepatitis C virus infection in 8 weeks, with a regimen currently approved for 12 weeks, could enable shorter, less costly treatment.
Second Case of Rat Hepatitis E Virus Identified in Hong Kong
Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.
SVR Possible in PWID Infected With Hepatitis C Virus Despite Imperfect Adherence to Treatment
People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.
Hepatitis C Treatment Time Could Be Cut in Half in Some Patients: A Proof of Concept Study
A new approach to hepatitis C virus infection treatment could shave time and costs off the current standard regimen.
HIV and NAFLD More Common Than Originally Thought
Research on nonalcoholic fatty liver disease in persons infected with HIV revealed a prevalence of the condition of about 40%, suggesting the condition may be an underappreciated comorbidity in this population.